(B) in paragraph (2)(D), by striking 
‘‘(17)’’ and inserting ‘‘(18)’’. 
SEC. 6. REGISTRATION REQUIREMENTS FOR SCHEDULE A 
SUBSTANCES. 
(a) REGISTRATION REQUIREMENTS FOR IMPORTERS 
AND EXPORTERS OF SCHEDULE A SUBSTANCES.—Sec-
tion 1008 of the Controlled Substances Import and Export 
Act (21 U.S.C. 958) is amended by adding at the end the 
following: 
‘‘(j)(1) The Attorney General shall register an appli-
cant to import or export a schedule A substance if— 
‘‘(A) the applicant demonstrates that the sched-
ule A substance will be used for research, analytical, 
or industrial purposes approved by the Attorney 
General; and 
‘‘(B) the Attorney General determines that such 
registration is consistent with the public interest and 
with the United States obligations under inter-
national treaties, conventions, or protocols in effect 
on the date of enactment of this subsection. 
‘‘(2) In determining the public interest under para-
graph (1)(B), the Attorney General shall consider— 
‘‘(A) maintenance of effective controls against 
diversion of particular controlled substances and any 
controlled substance in schedule A compounded 
VerDate Sep 11 2014 
19:07 Oct 17, 2024
Jkt 059200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H9879.IH
H9879
ssavage on LAPJG3WLY3PROD with BILLS
therefrom into other than legitimate medical, sci-
entific, research, or industrial channels, by limiting 
the importation and bulk manufacture of such con-
trolled substances to a number of establishments 
which can produce an adequate and uninterrupted 
supply of these substances under adequately com-
petitive conditions for legitimate medical, scientific, 
research, and industrial purposes; 
‘‘(B) compliance with applicable State and local 
law; 
‘‘(C) promotion of technical advances in the art 
of manufacturing substances described in subpara-
graph (A) and the development of new substances; 
‘‘(D) prior conviction record of applicant under 
Federal and State laws relating to the importation, 
manufacture, distribution, or dispensing of sub-
stances described in subparagraph (A); 
‘‘(E) past experience in the importation and 
manufacture of controlled substances, and the exist-
ence in the establishment of effective control against 
diversion; and 
‘‘(F) such other factors as may be relevant to 
and consistent with the public health and safety. 
‘‘(3) If an applicant is registered to import or export 
a controlled substance in schedule I or II under subsection 
VerDate Sep 11 2014 
19:07 Oct 17, 2024
Jkt 059200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H9879.IH
H9879
ssavage on LAPJG3WLY3PROD with BILLS
(a), the applicant shall not be required to apply for a sepa-
rate registration under this subsection.’’. 
(b) RESEARCH ON SUBSTANCES NEWLY ADDED TO 
SCHEDULE A.—Section 302(e) of the Controlled Sub-
stances Act (21 U.S.C. 822(e)) is amended by adding at 
the end the following: 
‘‘(3)(A) If a person is conducting research on a sub-
stance at the time the substance is added to schedule A, 
and such person, subject to an exemption that is in effect 
for investigational use, for that person, under section 505 
of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
355) to the extent conduct with respect to such substance 
is pursuant to such exemption.’’. 
(c) CONTINUATION OF RESEARCH ON SUBSTANCES 
NEWLY ADDED TO SCHEDULE A.—Section 302(e) of the 
Controlled Substances Act (21 U.S.C. 822(e)), as amend-
ed by subsection (b) of this section, is amended by adding 
at the end the following: 
‘‘(B) If a person is conducting research on a sub-
stance at the time the substance is added to schedule A, 
and such person is already registered to conduct research 
with a controlled substance in schedule I or II, then— 
‘‘(i) the person shall, within 30 days of the 
scheduling of the newly-scheduled substance, submit 
a completed application for registration or modifica-
VerDate Sep 11 2014 
23:12 Oct 18, 2024
Jkt 059200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H9879.IH
H9879
ssavage on LAPJG3WLY3PROD with BILLS
tion of existing registration, to conduct research on 
such substance, in accordance with the regulations 
issued by the Attorney General; 
‘‘(ii) the person may continue to conduct the re-
search on such substance until the application de-
scribed in clause (i) is withdrawn by the applicant 
or until the Attorney General serves on the applicant 
an order to show cause proposing the denial of the 
application pursuant to section 304(c); and 
‘‘(iii) if the Attorney General serves order to 
show cause under clause (ii) and the applicant re-
quests a hearing, such hearing shall be held on an 
expedited basis and not later than 45 days after the 
request is made, except that the hearing may be held 
at a later time if so requested by the applicant. 
‘‘(C) A person who is registered to conduct research 
with a controlled substance in schedule A may conduct re-
search with another controlled substance in schedule I, 
only if— 
‘‘(i) the person has applied for a modification of 
the person’s registration to authorize research with 
such other controlled substance in accordance with 
the regulations issued by the Attorney General; 
‘‘(ii) 
the 
Attorney 
General 
has 
obtained 
verification from the Secretary that the research 
VerDate Sep 11 2014 
19:07 Oct 17, 2024
Jkt 059200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H9879.IH
H9879
ssavage on LAPJG3WLY3PROD with BILLS
protocol submitted with the application is meri-
torious; and 
‘‘(iii) the Attorney General has determined, not 
later than 30 days after receiving the application de-
scribed in clause (i), that such activity is consistent 
with United States obligations under the Single Con-
vention on Narcotic Drugs, 1961. 
‘‘(D) Nothing in this paragraph shall be construed 
to alter the authority of the Attorney General to initiate 
proceedings to deny, suspend, or revoke any registration 
in accordance with sections 303 and 304.’’. 
SEC. 7. ADDITIONAL CONFORMING AMENDMENTS. 
The Controlled Substances Import and Export Act 
(21 U.S.C. 951 et seq.) is amended— 
(1) in section 1002(a) (21 U.S.C. 952(a))— 
(A) in the matter preceding paragraph (1), 
by inserting ‘‘or drug or substance in schedule 
A’’ after ‘‘schedule I or II’’; and 
(B) in paragraph (2), by inserting ‘‘or 
drug or substances in schedule A’’ after ‘‘sched-
ule I or II’’; 
(2) in section 1003 (21 U.S.C. 953)— 
(A) in subsection (c), in the matter pre-
ceding paragraph (1), by inserting ‘‘or drug or 
VerDate Sep 11 2014 
19:07 Oct 17, 2024
Jkt 059200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H9879.IH
H9879
ssavage on LAPJG3WLY3PROD with BILLS
substance in schedule A’’ after ‘‘schedule I or 
II’’; and 
(B) in subsection (d), by inserting ‘‘or 
drug or substance in schedule A’’ after ‘‘sched-
ule I or II’’; 
(3) in section 1004(1) (21 U.S.C. 954(1)), in 
the matter preceding subparagraph (A), by inserting 
‘‘or drug or substance in schedule A’’ after ‘‘sched-
ule I’’; 
(4) in section 1005 (21 U.S.C. 955), by insert-
ing ‘‘or drug or substance in schedule A’’ after 
‘‘schedule I or II’’; and 
(5) in section 1009(a) (21 U.S.C. 959(a)), by 
inserting ‘‘or drug or substance in schedule A’’ after 
‘‘schedule I or II’’. 
SEC. 8. SENTENCING REVIEW. 
(a) COVERED OFFENSE DEFINED.—In this section, 
the term ‘‘covered offense’’ means an offense involving a 
schedule A substance for which the penalty was estab-
lished under section 4 or 5 of this Act. 
(b) SENTENCING REVIEW.— 
(1) PETITION FOR REVIEW.—If a schedule A 
substance that is temporarily or permanently sched-
uled under section 201(k) of the Controlled Sub-
stances Act, as added by this Act, is subsequently 
VerDate Sep 11 2014 
19:07 Oct 17, 2024
Jkt 059200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H9879.IH
H9879
ssavage on LAPJG3WLY3PROD with BILLS